Cargando…

Inactivated Platelet Lysate Supports the Proliferation and Immunomodulant Characteristics of Mesenchymal Stromal Cells in GMP Culture Conditions

Mesenchymal stromal cells (MSCs) isolated from bone marrow (BM-MSCs) are considered advanced therapy medicinal products (ATMPs) and need to be produced according to good manufacturing practice (GMP) in their clinical use. Human platelet lysate (HPL) is a good GMP-compliant alternative to animal seru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mareschi, Katia, Castiglia, Sara, Adamini, Aloe, Rustichelli, Deborah, Marini, Elena, Banche Niclot, Alessia Giovanna Santa, Bergallo, Massimiliano, Labanca, Luciana, Ferrero, Ivana, Fagioli, Franca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400095/ https://www.ncbi.nlm.nih.gov/pubmed/32708843 http://dx.doi.org/10.3390/biomedicines8070220

Ejemplares similares

A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions
por: Mareschi, Katia, et al.
Publicado: (2022)

Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions
por: Castiglia, Sara, et al.
Publicado: (2014)

A New Human Platelet Lysate for Mesenchymal Stem Cell Production Compliant with Good Manufacturing Practice Conditions Preserves the Chemical Characteristics and Biological Activity of Lyo-Secretome Isolated by Ultrafiltration
por: Mareschi, Katia, et al.
Publicado: (2022)

Cytokine-Induced Killer (CIK) Cells, In Vitro Expanded under Good Manufacturing Process (GMP) Conditions, Remain Stable over Time after Cryopreservation
por: Mareschi, Katia, et al.
Publicado: (2020)

Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity
por: Sara, Castiglia, et al.
Publicado: (2018)

Correction to: Cytokines induced killer cells produced in good manufacturing practices conditions: identification of the most advantageous and safest expansion method in terms of viability, cellular growth and identity
por: Castiglia, Sara, et al.
Publicado: (2018)

Validation of analytical methods in GMP: the disposable Fast Read 102® device, an alternative practical approach for cell counting
por: Gunetti, Monica, et al.
Publicado: (2012)

A Novel Xeno-Free Method to Isolate Human Endometrial Mesenchymal Stromal Cells (E-MSCs) in Good Manufacturing Practice (GMP) Conditions
por: Canosa, Stefano, et al.
Publicado: (2022)

A New Paclitaxel Formulation Based on Secretome Isolated from Mesenchymal Stem Cells Shows a Significant Cytotoxic Effect on Osteosarcoma Cell Lines
por: Banche Niclot, Alessia Giovanna Santa, et al.
Publicado: (2023)

State of the Art and New Trends from the 2022 Gism Annual Meeting
por: Ferrero, Ivana, et al.
Publicado: (2023)

Multipotent Mesenchymal Stromal Stem Cell Expansion by Plating Whole Bone Marrow at a Low Cellular Density: A More Advantageous Method for Clinical Use
por: Mareschi, Katia, et al.
Publicado: (2012)

Validation of analytical methods in compliance with good manufacturing practice: a practical approach
por: Rustichelli, Deborah, et al.
Publicado: (2013)

Evaluating Ecological Impact and Sustainability in the Manufacturing of Advanced Therapies: Comparative Analysis of Greenhouse Gas Emissions in the Production of ATMPs in Open and Closed Systems
por: Pinnetta, Giuseppe, et al.
Publicado: (2023)

Myogenic Potential of Whole Bone Marrow Mesenchymal Stem Cells In Vitro and In Vivo for Usage in Urinary Incontinence
por: Gunetti, Monica, et al.
Publicado: (2012)

Effect of In Vitro Exposure of Corticosteroid Drugs, Conventionally Used in AMD Treatment, on Mesenchymal Stem Cells
por: Nuzzi, Raffaele, et al.
Publicado: (2012)

Organotypic spinal cord cultures: An in vitro 3D model to preliminary screen treatments for spinal muscular atrophy
por: Boido, Marina, et al.
Publicado: (2021)

Precision Medicine in Osteosarcoma: MATCH Trial and Beyond
por: Tirtei, Elisa, et al.
Publicado: (2021)

Inter-laboratory method validation of CD34+ flow-cytometry assay: the experience of Turin Metropolitan Transplant Centre
por: Ivana Ferrero, I.F., et al.
Publicado: (2023)

Viral infections and wheezing–asthma inception in childhood: is there a role for immunomodulation by oral bacterial lysates?
por: Rossi, Giovanni A., et al.
Publicado: (2020)

PEG-Coated Large Mesoporous Silicas as Smart Platform for Protein Delivery and Their Use in a Collagen-Based Formulation for 3D Printing
por: Banche-Niclot, Federica, et al.
Publicado: (2021)

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine
por: Boudousquié, Caroline, et al.
Publicado: (2020)

Genetic and Epigenetic Characterization of a Discordant KMT2A/AFF1-Rearranged Infant Monozygotic Twin Pair
por: Russo, Alessia, et al.
Publicado: (2021)

Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience
por: Becherucci, Valentina, et al.
Publicado: (2018)

Clinical results of an inactivated anti-brucella vaccine in combination with immunomodulators
por: Bouchemla, Fayssal, et al.
Publicado: (2020)

Vaccination with Toxoplasma lysate antigen or its encapsulated niosomes form immunomodulates adjuvant-induced arthritis through JAK3 downregulation
por: Hassouna, Sally S., et al.
Publicado: (2023)

3D Printed Scaffold Based on Type I Collagen/PLGA_TGF-β1 Nanoparticles Mimicking the Growth Factor Footprint of Human Bone Tissue
por: Banche-Niclot, Federica, et al.
Publicado: (2022)

The Potential of GMP-Compliant Platelet Lysate to Induce a Permissive State for Cardiovascular Transdifferentiation in Human Mediastinal Adipose Tissue-Derived Mesenchymal Stem Cells
por: Siciliano, Camilla, et al.
Publicado: (2015)

Bioengineered tissue and cell therapy products are efficiently cryopreserved with pathogen-inactivated human platelet lysate-based solutions
por: Martín-López, María, et al.
Publicado: (2023)

Cyclic di‐GMP inactivates T6SS and T4SS activity in Agrobacterium tumefaciens
por: McCarthy, Ronan R., et al.
Publicado: (2019)

High Variability of Mesenchymal Stem Cells Obtained via Bone Marrow Aspirate Concentrate Compared With Traditional Bone Marrow Aspiration Technique
por: Brozovich, Ava, et al.
Publicado: (2021)

Corrigendum: Heparan Sulfate: A Potential Candidate for the Development of Biomimetic Immunomodulatory Membranes
por: Corradetti, Bruna, et al.
Publicado: (2018)

Heparan Sulfate: A Potential Candidate for the Development of Biomimetic Immunomodulatory Membranes
por: Corradetti, Bruna, et al.
Publicado: (2017)

DeLTa-Seq: direct-lysate targeted RNA-Seq from crude tissue lysate
por: Kashima, Makoto, et al.
Publicado: (2022)

Enhanced Immune Responses in Mice Induced by the c-di-GMP Adjuvanted Inactivated Vaccine for Pseudorabies Virus
por: Hou, Liting, et al.
Publicado: (2022)

Antimicrobial Effects of Equine Platelet Lysate
por: Gordon, Julie, et al.
Publicado: (2021)

Cord Blood Platelet Lysate: In Vitro Evaluation to Support the Use in Regenerative Medicine
por: Valentini, Caterina Giovanna, et al.
Publicado: (2019)

Radiofrequency combined with immunomodulation for hepatocellular carcinoma: State of the art and innovations
por: da Costa, Adriano Carneiro, et al.
Publicado: (2020)

Improving the immunosuppressive potential of articular chondroprogenitors in a three-dimensional culture setting
por: Bauza, Guillermo, et al.
Publicado: (2020)

Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I
por: Frantz, Stefan, et al.
Publicado: (2013)

The Concept and Practice of Immunomodulation in Ayurveda and the Role of Rasayanas as Immunomodulators
por: Tripathi, J.S., et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_4ppi1ih166992fjudg4vd5vnms